Clinical trial
Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma
NCT02659618 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma
- Lead sponsor
- Rush University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- December 16, 2020
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
severe persistent asthma